Screening compound: HJPRWCALBCEKJR-UCQDPVIZSA-N

Screening compound: HJPRWCALBCEKJR-UCQDPVIZSA-N
Screening compound: HJPRWCALBCEKJR-UCQDPVIZSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
HJPRWCALBCEKJR-UCQDPVIZSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K204-0003

Molecular Formula

C44H55N3O10 (C44 H55 N3 O10)

Compound Name

N-[(1E)-1-{N'-[(E)-[3a,5a,7-trihydroxy-11a-methyl-1-(5-oxo-2,5-dihydrofuran-3-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-9a-yl]methylidene]hydrazinecarbonyl}-2-(4-ethylphenyl)eth-1-en-1-yl]-3,4,5-trimethoxybenzamide

IUPAC name

N-[(1E)-1-{N'-[(E)-[(3bR7R9bS)-3a5a7-trihydroxy-11a-methyl-1-(5-oxo-25-dihydrofuran-3-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-9a-yl]methylidene]hydrazinecarbonyl}-2-(4-ethylphenyl)eth-1-en-1-yl]-345-trimethoxybenzamide

SMILES

CCc1ccc(/C=C(\C(N/N=C/C(CC[C@H](C2)O)([C@@H](CCC3(C)C(CC4)C(CO5)=CC5=O)[C@@H](CC5)C34O)C25O)=O)/NC(c(cc2OC)cc(OC)c2OC)=O)cc1

InChI

InChI=1S/C44H55N3O10/c1-6-26-7-9-27(10-8-26)19-34(46-39(50)28-20-35(54-3)38(56-5)36(21-28)55-4)40(51)47-45-25-42-16-11-30(48)23-43(42,52)17-13-33-32(42)12-15-41(2)31(14-18-44(33,41)53)29-22-37(49)57-24-29/h7-10,19-22,25,30-33,48,52-53H,6,11-18,23-24H2,1-5H3,(H,46,50)(H,47,51)/t30-,31?,32+,33+,41?,42?,43?,44?/m0/s1

InChI Key

HJPRWCALBCEKJR-UCQDPVIZSA-N

MDL Number (MFCD)

MFCD02656704

HJPRWCALBCEKJR-UCQDPVIZSA-N in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

KRAS-Targeted Library (16000 compounds)

Lipid Metabolism Library (9174 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Steroid-like Compounds (494 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cardiovascular
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with HJPRWCALBCEKJR-UCQDPVIZSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound HJPRWCALBCEKJR-UCQDPVIZSA-N?
Check Price and Availability of HJPRWCALBCEKJR-UCQDPVIZSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of HJPRWCALBCEKJR-UCQDPVIZSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for HJPRWCALBCEKJR-UCQDPVIZSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for HJPRWCALBCEKJR-UCQDPVIZSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of HJPRWCALBCEKJR-UCQDPVIZSA-N available by request